Kurabi Arwa, Pak Kwang, Ryan Allen F, Wasserman Stephen I
School of Medicine, Department of Surgery, Division of Otolaryngology, University of California San Diego, 9500 Gilman Drive-MC#0666, La Jolla, CA, 92093-0666, USA.
Veterans Administration San Diego Healthcare System, 3350 Villa La Jolla Drive-MC#151, San Diego, CA, 92121, USA.
Curr Allergy Asthma Rep. 2016 Jan;16(1):6. doi: 10.1007/s11882-015-0585-2.
Otitis media (OM) is a common disease in young children, accounting for more office visits and surgeries than any other pediatric condition. It is associated with an estimated cost of five billion dollars annually in the USA. Moreover, chronic and recurrent middle ear (ME) disease leads to hearing loss during critical periods of language acquisition and learning leading to delays in reaching developmental milestones and risking permanent damage to the ME and inner ear in severe cases. Therefore, research to understand the disease pathogenesis and identify new therapeutics is important. Although OM is a multifactorial disease, targeting the molecular mechanisms that drive inflammation and OM resolution is critical. In this review, we discuss the current evidence suggesting that innate immune receptors and effectors play key roles in OM by mediating both the ME inflammatory responses and recovery.
中耳炎(OM)是幼儿的常见疾病,就诊和手术次数超过其他任何儿科疾病。在美国,其每年估计花费达50亿美元。此外,慢性和复发性中耳(ME)疾病会在语言习得和学习的关键时期导致听力损失,进而导致发育里程碑延迟,严重时还会有ME和内耳永久性损伤的风险。因此,了解疾病发病机制并确定新疗法的研究很重要。尽管OM是一种多因素疾病,但针对驱动炎症和OM消退的分子机制至关重要。在本综述中,我们讨论了当前证据,这些证据表明先天免疫受体和效应器通过介导ME炎症反应和恢复在OM中起关键作用。